【原著論文・症例報告】
1.

Akagi A, Iwasaki Y, Hashimoto R, Aiba I, Inukai A, Mimuro M, Riku Y, Miyahara H, Kitamoto
T and Yoshida M. A case of M232R genetic Creutzfeldt-Jakob disease with Lewy bodies. J

Neurol Sci. 2020; 409: 116605.
2.

Akagi A, Iwasaki Y, Yamamoto A, Matsuura H, Ikeda T, Mimuro M, Riku Y, Miyahara H,Kitamoto T and Yoshida M. Identification of intracerebral hemorrhage in the early-phase of
MM1+2C-type sporadic Creutzfeldt-Jakob disease: A case report. Neuropathology. 2020.

3.

Hamaguchi T, Sanjo N, Ae R, Nakamura Y, Sakai K, Takao M, Murayama S, Iwasaki Y, SatohK, Murai H, Harada M, Tsukamoto T, Mizusawa H and Yamada M. MM2-type sporadic
Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg

Psychiatry. 2020; 91(11): 1158-1165.
4.

Hayashi Y, Iwasaki Y, Waza M, Kato S, Akagi A, Kimura A, Inuzuka T, Satoh K, Kitamoto T,Yoshida M and Shimohata T. Clinicopathological findings of a long-term survivor of V180I
genetic Creutzfeldt-Jakob disease. Prion. 2020; 14(1): 109-117.

5.

Hayashi Y, Iwasaki Y, Yoshikura N, Yamada M, Kimura A, Inuzuka T, Miyahara H, Goto Y,Nishino I, Yoshida M and Shimohata T. Clinicopathological findings of a mitochondrial
encephalopathy, lactic acidosis, and stroke-like episodes/Leigh syndrome overlap patientwith a novel m.3482A>G mutation in MT-ND1. Neuropathology. 2020.

6.

Hirano M, Iritani S, Sekiguchi H, Torii Y, Habuchi C, Fujishiro H, Ozaki N, Yoshida M andFujita K. Background of the neuropathological site in neurocognitive decline in elderly
schizophrenic patients. Psychogeriatrics. 2020.

7.

Hirano M, Iritani S, Fujishiro H, Torii Y, Kawashima K, Sekiguchi H, Habuchi C, Yamada K,Ikeda T, Hasegawa M, Ikeuchi T, Yoshida M and Ozaki N. Globular glial tauopathy Type I
presenting with behavioral variant frontotemporal dementia. Neuropathology. 2020; 40(5):515-525.

8.

Ikeda T, Iwasaki Y, Sakurai K, Akagi A, Riku Y, Mimuro M, Miyahara H, Kitamoto T,Matsukawa N and Yoshida M. Correlating diffusion-weighted MRI intensity with type 2
pathology in mixed MM-type sporadic Creutzfeldt-Jakob disease. J Neurol Sci. 2020; 408:

116515.

9.

Ikeda T, Sakurai K, Matsukawa N and Yoshida M. Atrophic mammillary bodies withhypointensities on susceptibility-weighted images: A case-study in Korsakoff syndrome. JNeurol Sci. 2020; 408: 116551.
10. Imai K, Masuda M, Watanabe H, Ogura A, Ohdake R, Tanaka Y, Kato T, Kawabata K, RikuY, Hara K, Nakamura R, Atsuta N, Bagarinao E, Katahira K, Ohira H, Katsuno M and Sobue
G. The neural network basis of altered decision-making in patients with amyotrophic lateralsclerosis. Ann Clin Transl Neurol. 2020; 7(11): 2115-2126.

11. Ishigaki S, Riku Y, Fujioka Y, Endo K, Iwade N, Kawai K, Ishibashi M, Yokoi S, Katsuno M,Watanabe H, Mori K, Akagi A, Yokota O, Terada S, Kawakami I, Suzuki N, Warita H, Aoki
M, Yoshida M and Sobue G. Aberrant interaction between FUS and SFPQ in neurons in awide range of FTLD spectrum diseases. Brain. 2020.

12. Iwasaki Y. The Braak hypothesis in prion disease with a focus on Creutzfeldt-Jakob disease.

Neuropathology. 2020.
13. Kametani F, Yoshida M, Matsubara T, Murayama S, Saito Y, Kawakami I, Onaya M, Tanaka
H, Kakita A, Robinson A C, Mann D M A and Hasegawa M. Comparison of Common andDisease-Specific Post-translational Modifications of Pathological Tau Associated With a
Wide Range of Tauopathies. Front Neurosci. 2020; 14: 581936.

14. Komatsu H, Takeuchi H, Kikuchi Y, Ono C, Yu Z, Iizuka K, Takano Y, Kakuto Y, Funakoshi
S, Ono T, Ito J, Kunii Y, Hino M, Nagaoka A, Iwasaki Y, Yamamori H, Yasuda Y, Fujimoto M,Azechi H, Kudo N, Hashimoto R, Yabe H, Yoshida M, Saito Y, Kakita A, Fuse N, Kawashima
R, Taki Y and Tomita H. Ethnicity-Dependent Effects of Schizophrenia Risk Variants of theOLIG2 Gene on OLIG2 Transcription and White Matter Integrity. Schizophr Bull. 2020.

15. Lee Y H, Ando T, Lee J J, Baek M S, Lyoo C H, Kim S J, Kim M, Cho J W, Sohn Y H, Katsuno
M, Watanabe H, Yoshida M and Lee P H. Later-Onset Multiple System Atrophy: A
Multicenter Asian Study. Mov Disord. 2020.

16. Mimuro M and Yoshida M. Chameleons and mimics: Progressive supranuclear palsy andcorticobasal degeneration. Neuropathology. 2020; 40(1): 57-67.

17. Miwa A, Hirano M, Torii Y, Sekiguchi H, Habuchi C, Fujishiro H, Yoshida M, Iwai K,Kawashima K and Iritani S. Clinicopathological investigation of the background of cognitive
decline in elderly schizophrenia. Acta Neuropsychiatr. 2020: 1-7.

18. Nakano M, Riku Y, Nishioka K, Hasegawa M, Washimi Y, Arahata Y, Takeda A, Horibe K,Yamaoka A, Suzuki K, Tsujimoto M, Li Y, Yoshino H, Hattori N, Akagi A, Miyahara H, Iwasaki
Y and Yoshida M. Unclassified four-repeat tauopathy associated with familial parkinsonism
and progressive respiratory failure. Acta Neuropathol Commun. 2020; 8(1): 148.

19. Natsumeda M, Miyahara H, Yoshimura J, Nakata S, Nozawa T, Ito J, Kanemaru Y, Watanabe
J, Tsukamoto Y, Okada M, Oishi M, Hirato J, Wataya T, Ahsan S, Tateishi K, Yamamoto T,Rodriguez F J, Takahashi H, Hovestadt V, Suva M L, Taylor M D, Eberhart C G, Fujii Y andKakita A. GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNTActivated Medulloblastoma. J Neuropathol Exp Neurol. 2020.

20. Onodera K, Shimojo D, Ishihara Y, Yano M, Miya F, Banno H, Kuzumaki N, Ito T, Okada R,de Araújo Herculano B, Ohyama M, Yoshida M, Tsunoda T, Katsuno M, Doyu M, Sobue G,Okano H and Okada Y. Unveiling synapse pathology in spinal bulbar muscular atrophy bygenome-wide transcriptome analysis of purified motor neurons derived from disease specific
iPSCs. Mol Brain. 2020; 13(1): 18.

21. Riku Y. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43
aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Neuropathology. 2020.
22. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, NoguchiShinohara M, Nozaki I, Nakamura Y, Kitamoto T, Harada M, Mizusawa H and Yamada M.
Diffusion-weighted magnetic resonance imaging in dura mater graft-associated CreutzfeldtJakob disease. J Neurol Sci. 2020; 418: 117094.

23. Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin A G, Ghetti B, Matsubara T,
Tomita T, Ando T, Hasegawa K, Murayama S, Yoshida M, Hasegawa M, Scheres S H W andGoedert M. Structures of α-synuclein filaments from multiple system atrophy. Nature. 2020.

24. Sekiguchi K, Miyahara H, Inoue M, Maeda T and Ihara K. The autophagy reaction in thehuman umbilical cord: a potential marker for estimating fetal nutrition and neonatal growth.

J Matern Fetal Neonatal Med. 2020: 1-5.
25. Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki
M, Komatsu T, Nakamagoe K, Ikeda T, Yoshida M, Takahashi T, Ono H, Nishiyama S,Kuroda H, Nakashima I, Suzuki H, Bradl M, Lassmann H, Fujihara K and Aoki M. Myelin
oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.

Brain. 2020; 143(5): 1431-1446.
26. Torii Y, Iritani S, Marui T, Sekiguchi H, Habuchi C, Fujishiro H, Kushima I, Oshima K,Niizato K, Hayashida S, Masaki K, Kira J I, Yoshida M and Ozaki N. Morphological alterationof myelin-oligodendrocytes in a schizophrenic patient with 22q11.2 deletion syndrome: Anautopsy study. Schizophr Res. 2020; 223: 353-355.

27. Tsuboi T, Harada Y, Suzuki M, Ando T, Atsuta N, Ohka F, Takeuchi K, Taoka T, Ohba S,Nakaguro M, Abe M, Nakashima I, Yoshida M and Katsuno M. Steroid-responsive recurrent
tumefactive demyelination with multiple petechial hemorrhages along non-displaced
medullary veins. Clin Neurol Neurosurg. 2020; 193: 105764.

28. Uchida Y, Yoshida M, Takada K, Tsugu Y, Ueki Y and Matsukawa N. Corticobasal syndromePick's disease: A clinicopathological study. J Neurol Sci. 2020; 412: 116752.

29. Uchihara T, Shibata N and Yoshida M. Reconsidering the Braak-prion hypothesis: truths orrealities. Neuropathology. 2020; 40(5): 413-414.

30. Uchihara T, Yoshida M and Shibata N. Crosstalk between neuropathology and clinicalneurology: Fundamentals for clinical neurologists. Neuropathology. 2020; 40(1): 21.

31. Uemura M, Nozaki H, Kato T, Koyama A, Sakai N, Ando S, Kanazawa M, Hishikawa N,Nishimoto Y, Polavarapu K, Nalini A, Hanazono A, Kuzume D, Shindo A, El-Ghanem M, Abe
A, Sato A, Yoshida M, Ikeuchi T, Mizuta I, Mizuno T and Onodera O. HTRA1-Related
Cerebral Small Vessel Disease: A Review of the Literature. Front Neurol. 2020; 11: 545.

32. Watanabe R, Higashi S, Nonaka T, Kawakami I, Oshima K, Niizato K, Akiyama H, YoshidaM, Hasegawa M and Arai T. Intracellular dynamics of Ataxin-2 in the human brains withnormal and frontotemporal lobar degeneration with TDP-43 inclusions. Acta Neuropathol

Commun. 2020; 8(1): 176.

【商業誌】
1.

安藤 孝志, 勝野 雅央, 吉田 眞理（2020 年）．
【臨床に役立つ解剖・生理学】 局在診断に有用な神経解剖学．Medicina．57 巻 2 号，206-213 頁．

2.

安藤 孝志, 勝野 雅央（2020 年）．【救急でもう騙されない!ミミックとカメレオン 紛
らわしい疾患たちを見抜いて正しく診断・対処する】片頭痛のミミックとカメレオン．
レジデントノート．22 巻 10 号，1813-1820 頁．

3.

岩崎 靖（2020 年）．プリオン病 クロイツフェルト・ヤコブ病．新臨床内科学（第 10版）
．医学書院．1339-1340 頁.

4.

吉田 眞理 (2020 年). Lewy 小体病の自律神経障害と病理．脳神経内科. 92 巻 2 号，233240 頁.

【学会誌】
1.

吉田 眞理（2020 年）．レビー小体病の自律神経障害と病理．自律神経．57 巻 1 号，1014 頁．